|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Affymetrix Inc., of Santa Clara, Calif., entered a five-year collaboration with the Peter MacCallum Cancer Centre in Melbourne, Australia, to analyze genomic information across large patient samples. Researchers at the center will use Affymetrix GeneChip microarray technology for translational research projects, beginning with studies on ovarian cancer and carcinoma of unknown primaries. Peter Mac researchers will use Affymetrix GeneChip technology to perform large-scale clinical studies.
o Altana AG, of Bad Homburg, Germany, sold all of its stock in GPC Biotech AG, of Martinsried, Germany. The nearly 2.4 million shares, which equaled a stake of about 7.1 ...
Related newspaper, magazine, and journal articles:
|
|
Article: BioForce Nanosciences Takes Nano eNabler(TM) ...
PR Newswire Europe;
February 23, 2007 ;
700+ words
... ... February 23 /PRNewswire/ -- BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTC Bulletin ... This is possible because of BioForce Nanosciences' strong relationship with ...
|
|